ClinicalThought

Share

Program Content

Activities

  • Call to Action: TROP2 ADCs in Lung Cancer
    Call to Action: Misperceptions on TROP2-Targeted Antibody–Drug Conjugates in Lung Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 24, 2023

    Expires: February 23, 2024

  • TROP2 ADC + IO in NSCLC
    Combination Therapy With TROP2-Targeted Antibody–Drug Conjugates and Immunotherapy in Advanced/Metastatic NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 03, 2023

  • TROP2 ADCs for NSCLC 2023
    Progress in the Development of Antibody–Drug Conjugates Targeting TROP-2 for Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 19, 2023

Faculty

cover img faculity

Yasushi Goto, MD, PhD

Assistant Chief 
Department of Thoracic Oncology 
National Cancer Center Hospital Japan
Tokyo, Japan 

cover img faculity

Benjamin Levy, MD

Associate Professor
Johns Hopkins School of Medicine
Baltimore, Maryland

cover img faculity

Stephen V. Liu, MD

Associate Professor of Medicine
Director, Thoracic Oncology
Head, Developmental Therapeutics
Georgetown University
Washington, DC

Provided by

ProCE Banner

Supporters

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.